Tag Archives: Affordable Care Act

What the Affordable Care Act Means for Pharma Marketing

By Guest Blogger | Published: October 9, 2012
By Gregg DiPietro. With the Supreme Court’s decision in June to uphold the Patient Protection and Affordable Care Act (ACA), life science companies gained access to 32 million potential new customers. While that’s worth celebrating, the party may have ended before it began. For pharmaceutical companies to realize the benefits of new healthcare consumers, and to [...]
Posted in Guest Blog, Regulatory, Strategy | Also tagged , , , , | Leave a comment

Affordable Care Act: Where's the Sunshine?

By Guest Blogger | Published: September 7, 2012
Where’s the Sunshine? The Senate Special Committee on Aging is holding a Roundtable discussion on Wed. Sept. 12, 2012 in hopes of spurring action to implement the “Sunshine” provisions of the Affordable Care Act (ACA). Policies for collecting and submitting information on pharma payments to doctors were supposed to be issued by last September (2011), so [...]
Posted in Guest Blog, Op-Ed, Regulatory, healthcare | Also tagged , , , | Leave a comment

Drug Reimbursement and the "New Medicaid"

By Guest Blogger | Published: August 9, 2012
by Tom Norton A lot has been written about the “state option” created by the Supreme Court ruling on HCR, and what it means to American medicine. Sorting out an opinion will, to a degree, depend on whom you read and what you believe. But regardless of where you come out on this issue, there is little [...]
Posted in Guest Blog, Legal, Market Access, R&D, Regulatory, healthcare | Also tagged , , , , , , , | 1 Comment

Health Reform Declared Constitutional

By Jill Wechsler | Published: June 28, 2012
It’s back to business for pharma and biotech companies. The main result of the Supreme Court decision upholding the Affordable Care Act (ACA) is that it ends all the rampant speculation and uncertainty about the future shape of the U.S. healthcare system. Now healthcare providers, insurers, medical products makers, and government agencies can move forward with [...]
Posted in Strategy | Also tagged | Leave a comment

Less is More: HHS Austerity Care

By Guest Blogger | Published: May 1, 2012
By Tom Norton As the US Department of Health and Human Services (HHS) circles around the elements of health care that will actually be included in our new “Essential Health Benefits” (EHB), one aspect of the EHB offering has caused a tremendous stir among dozens of health groups.  Their collective concern is focused on the pharmaceutical [...]
Posted in Guest Blog, Legal, Regulatory, compliance, healthcare | Also tagged , , , , , , , | Leave a comment